-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharmaceutical Network January 8th, January 7th, NMPA official website shows that Nanjing Zhengda Tianqing, Yangzijiang Pharmaceutical Group, Nanjing Sheng and Pharmaceuticals injection of Parecheb sodium through a consistent evaluation.
January 6, Haizheng Pharmaceuticals announced that the company's injection of parrexib sodium over-evaluation.
injection with parexib sodium for the fourth batch of harvest varieties, so far 11 pharmaceutical companies have been evaluated.
Parexib belongs to nonsteroidal anti-inflammatory drugs, is the world's first simultaneous intravenous, intramuscular injection of selective epoxygenase-2 inhibitors, compared with traditional non-selective epoxyase inhibitors, with good analgesic effect, rapid effect, long-lasting effect, can effectively suppress pain hypersensitivity, high gastrointestinal safety, does not affect platelet function, does not increase cardiovascular risk and so on. according to
meters of intranet data, in 2019 China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal injection of Parrisheb sodium sales of nearly 2 billion yuan, 2020H1 sales of more than 900 million yuan, an increase of 14.57 percent year-on-year.
injection with Parexib sodium has previously been evaluated enterprise sources: Mi-Net consistency evaluation database injection with Parexib sodium for the fourth batch of collection varieties, before there have been Colum, Qiru, Osaikang ... 8 companies have been evaluated.
With nanjing Zhengda Tianqing, Yangzijiang Pharmaceutical Group, Nanjing Sheng and pharmaceutical companies such as the product evaluation, the current injection of Parexib sodium evaluation enterprises have reached 11.
so fierce competition, the fourth batch of the collection of the price of the variety is worth paying attention to.
source: MiNet Database, NMPA